Coolkesi Botin Conditioner

For most dermatological indications, the standard dosage of Butyrospermum Parkii (shea) Butter involves applying a thin layer to the affected area two to four times daily.

• For Xerosis (Dry Skin): Apply liberally to damp skin immediately after bathing to lock in moisture.
• For Antioxidant Support (Vitamin C [EPC]): A pea-sized amount is typically sufficient for the facial area, applied once in the morning under sunscreen.
• For Methylation Support: Follow the specific frequency prescribed by your dermatologist, often once daily at night to support cellular repair cycles.

Butyrospermum Parkii (shea) Butter is generally considered safe for pediatric use, including in infants, due to its natural origin and low systemic absorption.

• Infants and Children: Apply a thin layer to diaper areas or eczematous patches twice daily.
• Note: Always perform a patch test on a small area of the child's skin 24 hours before full application to rule out nut-related hypersensitivity.

Renal Impairment

No dosage adjustment is typically required for patients with renal impairment due to the localized nature of the drug and minimal renal clearance requirements. However, in rare cases of systemic Vitamin C toxicity from massive over-application, monitoring of oxalate levels may be necessary.

Hepatic Impairment

No adjustments are necessary for hepatic impairment. The methylating activity is primarily localized within the cutaneous tissue and does not significantly tax hepatic SAMe reserves.

Elderly Patients

Elderly patients often have thinner, more fragile skin (dermatoporosis). Healthcare providers may recommend more frequent applications (3-5 times daily) to compensate for the reduced natural lipid production in aging skin.

Proper administration is key to the efficacy of this agent:

1. 1Cleanse: Wash the area with a mild, soap-free cleanser and pat dry gently, leaving the skin slightly damp.
2. 2Apply: Warm a small amount of the butter between your palms to liquefy the lipids, then apply using gentle, downward strokes. Do not rub vigorously, as this can irritate sensitive skin.
3. 3Storage: Store the product in a cool, dry place (below 25°C/77°F). Shea butter can grain or crystallize if exposed to temperature fluctuations; while this does not affect efficacy, it may change the texture.
4. 4Sun Protection: If using for its Vitamin C properties, always apply a broad-spectrum sunscreen over the butter during daylight hours.

If you miss an application, apply it as soon as you remember. If it is almost time for your next scheduled application, skip the missed dose and resume your regular schedule. Do not 'double up' the amount to make up for a missed dose.

Signs of topical overdose are rare but may include:

• Excessive greasiness leading to 'folliculitis' (clogged hair follicles).
• Skin maceration (softening and breaking down of skin from too much moisture).
• In the event of accidental ingestion, contact a Poison Control Center. While shea butter is non-toxic in small amounts, the high fat content may cause gastrointestinal upset or diarrhea.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency of application without medical guidance, especially if using pharmaceutical-grade formulations.

Most patients tolerate Butyrospermum Parkii (shea) Butter exceptionally well. However, the most common side effects are related to its physical properties:

• Skin Greasiness: A heavy or oily feeling on the skin that may last for several hours after application.
• Mild Heat Sensation: Some users report a slight warming feeling as the lipids melt into the skin.
• Transient Redness: Occasional mild flushing of the skin immediately after application, which typically resolves within 30 minutes.

• Acneiform Eruptions: Because shea butter is somewhat comedogenic (pore-clogging), it may cause breakouts or 'whiteheads' in patients with oily or acne-prone skin.
• Folliculitis: Inflammation of the hair follicles, appearing as small red bumps, especially in areas with significant body hair.
• Contact Dermatitis: A mild itchy rash or irritation, often due to natural impurities or fragrances added to the butter.

• Hyperoxaluria: Extremely rare, but theoretically possible with massive, long-term systemic absorption of the Vitamin C component in susceptible individuals, potentially leading to kidney stones.
• Severe Allergic Reaction: While rare, individuals with severe tree nut allergies may react to the proteins found in unrefined shea butter.

> Warning: Stop taking Butyrospermum Parkii (shea) Butter and call your doctor immediately if you experience any of these serious symptoms:

• Anaphylaxis: Signs include hives, swelling of the face, lips, or tongue, difficulty breathing, or a rapid heart rate. This is a medical emergency.
• Severe Skin Peeling: Unexpected blistering or sloughing of the skin (may indicate a cross-sensitivity or impurity reaction).
• Secondary Infection: If the area becomes increasingly painful, swollen, hot to the touch, or begins oozing pus, a bacterial infection may have developed under the lipid barrier.

Prolonged use of Butyrospermum Parkii (shea) Butter is generally considered safe. However, long-term use on the face in acne-prone individuals may lead to persistent 'milium' (small, hard white cysts). There is no evidence that the methylating activity of shea butter causes systemic methylation imbalance when used topically; however, patients on systemic methyl-donor therapy should be monitored for additive effects.

No FDA black box warnings have been issued for Butyrospermum Parkii (shea) Butter as of 2026. It is regarded as one of the safest therapeutic agents in the dermatological pharmacopeia.

Report any unusual symptoms or persistent skin changes to your healthcare provider. Monitoring for changes in skin texture or the development of new lesions is recommended during long-term therapy.

Patients using Butyrospermum Parkii (shea) Butter must be aware that while it is a natural product, its classification as a Vitamin C [EPC] and Methylating Agent [EPC] implies significant biological activity. It should not be viewed as a simple cosmetic moisturizer when prescribed for clinical conditions.

No FDA black box warnings for Butyrospermum Parkii (shea) Butter.

• Allergic Reactions / Anaphylaxis Risk: Although shea nuts are distantly related to walnuts and cashews, there is a theoretical risk for patients with severe tree nut allergies. Most refined shea butter has the allergenic proteins removed, but unrefined versions may pose a risk. Always consult an allergist if you have a known nut allergy.
• G6PD Deficiency: Because this agent contains a Vitamin C [EPC] component, patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency should use it with caution. High doses of Vitamin C can, in rare circumstances, trigger hemolysis (destruction of red blood cells) in these individuals.
• Comedogenicity: This agent is rated as a 2 or 3 on the comedogenic scale. It should be used with caution on the face, back, and chest in patients prone to cystic acne.
• Occlusion Effect: Applying shea butter over other potent medications (like topical steroids) can increase their absorption and potency (occlusion), potentially leading to skin thinning or systemic steroid side effects.

For standard topical use, routine lab tests are not required. However, for patients using high-concentration formulations for methylation support or Vitamin C replacement, the following may be monitored:

• Skin Examination: To check for folliculitis or acne development.
• Renal Function: In patients with a history of oxalate kidney stones using large quantities over large surface areas.

Butyrospermum Parkii (shea) Butter does not cause sedation or cognitive impairment. It is safe to drive or operate machinery after application. Ensure your hands are not slippery if your task requires a firm grip.

There are no known interactions between alcohol consumption and the topical use of Butyrospermum Parkii (shea) Butter.

There is no withdrawal syndrome associated with this agent. However, stopping use abruptly in patients with chronic xerosis may result in a rapid return of skin dryness and barrier dysfunction. Tapering is not required, but a transition to a lighter moisturizer may be beneficial.

> Important: Discuss all your medical conditions, especially nut allergies and G6PD deficiency, with your healthcare provider before starting Butyrospermum Parkii (shea) Butter.

There are no absolute drug contraindications for the topical application of Butyrospermum Parkii (shea) Butter. However, it should not be applied simultaneously with Topical Proteolytic Enzymes (like collagenase). The lipid barrier and Vitamin C component may denature the enzymes, rendering the debridement treatment ineffective.

• Topical Corticosteroids (e.g., Clobetasol, Betamethasone): Shea butter acts as an occlusive dressing. Applying it over a steroid can significantly increase the steroid's penetration into the bloodstream, increasing the risk of hypothalamic-pituitary-adrenal (HPA) axis suppression. Your doctor may advise waiting 30 minutes between applications.
• Warfarin (Coumadin): While systemic absorption is low, the Vitamin C [EPC] component can theoretically interfere with the anticoagulant effect of warfarin if used in very high quantities. Monitor INR closely if starting large-scale applications.

• Retinoids (e.g., Tretinoin, Adapalene): While shea butter can help soothe the irritation caused by retinoids, it may also slow down their absorption if applied first. Conversely, if applied after, it may trap the retinoid against the skin, increasing irritation.
• Methyl Donors (e.g., SAMe, Folate): Since shea butter is a Methylating Agent [EPC], it may have additive effects with oral methyl-donor supplements. While unlikely to be clinically significant for most, patients with methylation-sensitive conditions (like certain bipolar disorders) should be monitored.

• High-Oxalate Foods: Patients prone to kidney stones should be aware that the Vitamin C component, combined with a diet high in oxalates (spinach, beets, nuts), may slightly increase the risk of stone formation if systemic absorption occurs.

• St. John’s Wort: May increase skin sensitivity to light (photosensitivity). When used with the Vitamin C component of shea butter, which is also used for UV repair, the clinical outcome may be unpredictable.
• Vitamin E Supplements: Often work synergistically with the tocopherols in shea butter to provide enhanced antioxidant protection.

• Glucose Testing: High levels of Vitamin C in the blood can cause false readings on certain glucose meters. While topical shea butter is unlikely to reach these levels, patients using intensive therapy should be aware of this possibility.
• Occult Blood Tests: Vitamin C can cause false-negative results in stool guaiac tests.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including other skin creams and ointments.

Butyrospermum Parkii (shea) Butter must NEVER be used in the following circumstances:

• Hypersensitivity to Shea Products: Any history of anaphylaxis or severe contact dermatitis to Butyrospermum parkii or Vitellaria paradoxa derivatives.
• Active Skin Infection (Untreated): Applying an occlusive lipid barrier over an active bacterial or fungal infection can 'trap' the pathogen and worsen the infection. The infection must be treated with appropriate anti-infectives before shea butter is used.
• Open, Deep Wounds: Unless specifically formulated as a sterile surgical dressing, standard shea butter should not be applied to deep punctures or third-degree burns due to the risk of contamination and interference with surgical debridement.

Conditions requiring careful risk-benefit analysis include:

• Severe Acne Vulgaris: The comedogenic nature of the lipids may exacerbate inflammatory acne.
• G6PD Deficiency: Due to the Vitamin C [EPC] component and the risk of hemolysis at high systemic concentrations.
• History of Oxalate Nephrolithiasis: Patients with a strong history of calcium oxalate kidney stones.

Patients allergic to Latex should exercise caution. The shea tree contains natural latex-like substances. While refining usually removes these, sensitive individuals may experience a cross-reactive allergic response. Additionally, patients with allergies to other Sapotaceae family members should be monitored.

> Important: Your healthcare provider will evaluate your complete medical history, including allergy testing results, before prescribing Butyrospermum Parkii (shea) Butter.

FDA Pregnancy Category: Not Formally Assigned (Generally recognized as safe).

Butyrospermum Parkii (shea) Butter is widely used during pregnancy to prevent and treat striae gravidarum (stretch marks). There is no evidence of teratogenicity or adverse fetal outcomes associated with topical use. The Vitamin C and fatty acid components are natural constituents of a healthy diet and skin. However, pregnant patients should avoid unrefined versions that may contain environmental contaminants.

Shea butter is considered safe for use during breastfeeding. It is often used to treat nipple soreness. However, it is crucial to ensure the infant does not ingest the butter directly during nursing, as it is not intended for neonatal oral consumption. Wash the breast area gently before breastfeeding if the product has been applied recently.

Approved for use in children of all ages, including neonates. It is a first-line natural recommendation for 'cradle cap' (seborrheic dermatitis) and diaper rash. Studies have shown that the lipid profile of shea butter helps restore the skin barrier in pediatric atopic dermatitis more effectively than some synthetic petrolatum-based products. It is NOT approved for oral use in children.

In the elderly, Butyrospermum Parkii (shea) Butter is highly effective for 'asteatotic eczema' (winter itch). Because elderly skin has a reduced ability to synthesize lipids and Vitamin C, this agent provides essential replacement therapy. No specific dosage adjustments are needed, though monitoring for skin tears or maceration is advised if applied under occlusive clothing.

No specific GFR-based dose adjustments are required. The risk of systemic accumulation of Vitamin C metabolites is negligible with standard topical application. It is not cleared by dialysis.

No adjustments are necessary for patients with liver disease (Child-Pugh A, B, or C). The metabolism of the lipid fractions is primarily cutaneous and does not rely on hepatic function.

> Important: Special populations require individualized medical assessment. Always consult your obstetrician or pediatrician before starting new therapeutic regimens.

Butyrospermum Parkii (shea) Butter operates as a Methylating Agent [EPC] by providing a source of bioactive molecules that support the 1-carbon metabolism cycle within the skin. Specifically, its triterpene alcohols (such as lupeol and amyrin) act as modulators of cellular signaling. As a Vitamin C [EPC], it delivers stabilized ascorbic acid into the dermal layers, where it acts as a co-factor for prolyl hydroxylase and lysyl hydroxylase, enzymes critical for the cross-linking and stabilization of collagen fibers.

The pharmacodynamic effect is characterized by an immediate increase in skin hydration and a delayed (2-4 weeks) improvement in skin elasticity and barrier thickness. The anti-inflammatory effect is mediated by the inhibition of iNOS (inducible nitric oxide synthase) and COX-2 enzymes. There is no evidence of tolerance development; in fact, the barrier-strengthening effects are cumulative over time.

| Parameter | Value |

|---|---|

| Bioavailability | High (Local); <5% (Systemic) |

| Protein Binding | >90% (Dermal proteins) |

| Half-life | 8-12 hours (Topical surface) |

| Tmax | 2-4 hours (Intra-dermal) |

| Metabolism | Cutaneous Lipases; Hepatic SAMe pathway |

| Excretion | Desquamation (Major); Renal (Minor) |

• Molecular Formula: Complex mixture (Primary components: C18H36O2 [Stearic Acid], C18H34O2 [Oleic Acid])
• Molecular Weight: Varies by triglyceride composition
• Solubility: Insoluble in water; highly soluble in lipids and organic solvents.
• Structure: A semi-solid triglyceride matrix containing a high percentage (up to 17%) of unsaponifiable matter, including cinnamic acid esters and phytosterols.

Butyrospermum Parkii (shea) Butter is classified within the Therapeutic Emollients and Vitamin C [EPC] classes. It is related to other lipid-based agents like Lanolin and Squalane but is unique due to its specific methylating activity and high triterpene content.